Stimulating Access to Research in Residency (StARR) - NHLBI

摘要/项目摘要 为了应对30年来内科科学家数量的下降，将其归因于长期的临床培训， 教育债务翻了一番或三倍，赠款资金前景不明朗，职业发展轨迹不明确，缺乏 在早期临床培训期间的指导研究机会中，NIH启动了指导研究路径 在驻留R38计划中。住院医师培训是医生培训的关键步骤，通常是通过培训来进行的 不支持医生-科学家发展的计划。受保护的研究存在重大差距 时间，有组织的培训和指导，以及返回诊所后继续研究的支持。初级阶段 多学科杜克大学NHLBI科学家-临床医生-研究人员在 住院医师(Duke SCI-STAR)计划是培养一支多样化的内科-科学家干部队伍，他们将领导 预防、诊断和治疗疾病的新临床模式的开发、实施和评估 在整个生命过程中影响心脏、肺和血液的状态。Duke NHLBI SCI-STAR培训居民 跨3个部门：儿科、内科和外科沿线地区的完整生物医学研究 连续体(基础/转化型、早期临床试验和药代动力学、晚期临床试验 试验和结果)，主题是改善生命过程中的健康。该计划将由四个项目组成 培训目标：1)涵盖基础、翻译、临床研究和专业的全面教学 发展；2)发展和完成一个研究项目和个性化的职业发展 计划；3)建立学术活动的跟踪记录；4)获得董事会认证的资格和 继续进行分专业培训。Duke NHLBI SCI-STARR将由以下执行委员会(EC)领导 医学硕士Mai K.ElMallah(儿科)、Scott Palmer(医学)、MHS(医学)和David HarpolJr. (外科)，以及扩大的派驻计划主任和计划协调员组成的EC，利用 由33名多部门、多学科、资金雄厚和经验丰富的教员组成的团队。这 申请申请每年支持三名驻地调查员，每名实习生支持18- 24个月的研究。完成该计划后，这些人员将能够过渡到 研究-密集的奖学金培训，成功地竞争外部资金，以支持一条 独立成为内科科学家，成为领导和指导下一代内科医生 以临床为导向，研究影响心脏、肺和血液的疾病状态的受训人员。取得的成就 该计划的目标将满足以下迫切的医疗需求：1)更多全职学术内科医生-研究人员 和全国医学院的导师；2)小说的创新和临床翻译 在整个生命过程中改善个人健康的战略。

ABSTRACT / PROJECT SUMMARY In response to a 30-year decline in the number of physician-scientists, attributed to prolonged clinical training, doubling or tripling of education debt, uncertain grant funding prospects, unclear career trajectories, and a lack of mentored research opportunities during early clinical training, the NIH started the Mentored ResearchPathway in Residency R38 program. Residency training, a critical step in physician training, is often carried out by training programs that do not support physician-scientist development. Significant gaps exist for protected research time, structured trainingand mentoring, and support to continue researchafter returningto the clinic. The primary goal of the multidisciplinary Duke NHLBI Scientist-Clinician-Investigator Stimulating access to Research during Residency (Duke SCI-StARR) program is to train a diverse cadre of physician-scientists who will lead the development, implementation, and evaluation of new clinical modalities to prevent, diagnose, and treat disease states affecting the heart, lungs, and blood throughout the life-course. Duke NHLBI SCI-StARR trainS residents across 3 departments: Pediatrics, Medicine, and Surgery in areas along the full biomedical research continuum (basic/translational, early phase clinical trials and pharmacokinetics, and late phase clinical trials and outcomes) with a theme of improving health over the life course. The program will consist of four training aims: 1) comprehensive didactics covering basic, translational, and clinical research and professional development; 2) development and completion of a research project and an individualized career development plan; 3) establishment of a track record of scholarly activity; and 4) eligibility for board certification and continuation to subspecialty training. Duke NHLBI SCI-StARR will be led by an Executive Committee (EC) of MPIs Mai K. ElMallah, MD (Pediatrics), Scott Palmer, MD, MHS (Medicine), and David Harpole, Jr., MD (Surgery), and an Expanded EC of Residency Program Directors and Program Coordinators, capitalizing on a team of 33 multi-departmental, multi-disciplinary, well-funded, and experienced faculty preceptors. This application requests support for three Resident-Investigators each year with each trainee to be supported for 18- 24 months of research. Upon completion of the program, these individuals will be capable of transitioning to research-intense fellowship training, successfully competing for extramural funding to support a path to independence as physician-scientists, and becoming the next generation of physicians leading and mentoring trainees in clinically-oriented research of disease states affecting the heart, lungs, and blood. Achievement of the program's objectives will fulfill urgent medical needs for: 1) more full-time academic physician-researchers and mentors in medical schools throughout the country and 2) innovations and clinical translation of novel strategies to improve the health of individuals across the life course.